PREFORMED LINE PRODUCTS CO·4

Mar 13, 4:51 PM ET

Morcos Assaad A 4

4 · PREFORMED LINE PRODUCTS CO · Filed Mar 13, 2026

Research Summary

AI-generated summary of this filing

Updated

Preformed Line Products (PLPC) VP Morcos Exercises Options, Sells Shares

What Happened

  • Morcos Assaad A, Vice President, US Manufacturing at Preformed Line Products (PLPC), exercised stock options and immediately disposed of part of the shares. The filing shows two option exercises of 1,750 shares each (3,500 total) at an exercise price of $132.40 per share.
  • One exercise resulted in acquisition of 1,750 shares (cost $231,700). Simultaneously, 1,750 shares were disposed to the issuer at $260.34 per share, producing proceeds of $455,595. Net effect in the filing: 3,500 shares exercised, 1,750 sold to the issuer, and 1,750 retained.

Key Details

  • Transaction date: March 10, 2026.
  • Exercise price: $132.40 per share; exercise cost for 3,500 shares = $463,400.
  • Disposition price to issuer: $260.34 per share; proceeds for 1,750 shares = $455,595.
  • Shares owned after transaction: not specified in the provided excerpt of the Form 4.
  • Relevant footnotes: F1 — 7,500 options were granted on Dec 11, 2024 (vesting: 3,750 on 12/11/2025, 1,875 on 12/11/2026, 1,875 on 12/11/2027; 10-year term). F2 — restricted stock units vest three years from grant (mentioned in filing but not directly part of this trade).
  • Filing timeliness: no late filing flag indicated in the provided data.

Context

  • This looks like a cashless or net-share exercise: options were exercised and a portion of the resulting shares was surrendered/sold to the issuer (commonly done to cover exercise costs or tax withholding). Such sales are often routine and do not necessarily signal a change in insider sentiment.
  • For retail investors, purchases (insiders acquiring shares with cash) are typically more informative than routine option exercises followed by share surrender/sale. This filing documents an exercise with partial disposition, not an open-market purchase.

Insider Transaction Report

Form 4
Period: 2026-03-10
Morcos Assaad A
VP, US Manufacturing
Transactions
  • Exercise/Conversion

    Common Shares, $2 par value per share

    [F1]
    2026-03-10$132.40/sh+1,750$231,7001,750 total
  • Disposition to Issuer

    Common Shares, $2 par value per share

    2026-03-10$260.34/sh1,750$455,5950 total
  • Exercise/Conversion

    Employee stock option (right to buy)

    [F1]
    2026-03-10$132.40/sh1,750$231,7004,750 total
    Exercise: $132.40Common Shares, $2 par value per share (1,750 underlying)
Holdings
  • Restricted stock units

    [F2]
    Exercise: $0.00Common shares, $2 par value (681 underlying)
    681
  • Restricted stock units

    [F2]
    Exercise: $0.00Common shares, $2 par value (407 underlying)
    407
Footnotes (2)
  • [F1]On December 11, 2024, the reporting person was granted 7,500 stock options, of which 3,750 vested on December 11, 2025, 1,875 will vest on December 11, 2026, and the remaining 1,875 will vest on December 11, 2027. The expiration date is 10 years from the grant date.
  • [F2]Restricted stock units vest 3 years from the date of grant.
Signature
/s/ Caroline S Vaccariello, by power of attorney|2026-03-13

Documents

1 file
  • 4
    wk-form4_1773435080.xmlPrimary

    FORM 4